Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 132,438,096
  • Shares Outstanding, K 1,473,827
  • Annual Sales, $ 14,240 M
  • Annual Income, $ 1,591 M
  • EBIT $ 3,351 M
  • EBITDA $ 4,605 M
  • 60-Month Beta 0.80
  • Price/Sales 9.21
  • Price/Cash Flow 30.64
  • Price/Book 6.26

Options Overview Details

View History
  • Implied Volatility 16.72% ( -6.93%)
  • Historical Volatility 18.59%
  • IV Percentile 4%
  • IV Rank 10.23%
  • IV High 34.64% on 10/11/24
  • IV Low 14.68% on 08/13/24
  • Put/Call Vol Ratio 0.74
  • Today's Volume 1,729
  • Volume Avg (30-Day) 5,090
  • Put/Call OI Ratio 1.10
  • Today's Open Interest 202,365
  • Open Int (30-Day) 190,340

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.65
  • Number of Estimates 11
  • High Estimate 0.66
  • Low Estimate 0.64
  • Prior Year 0.55
  • Growth Rate Est. (year over year) +18.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.25 +4.38%
on 12/20/24
91.59 -0.57%
on 12/16/24
+1.07 (+1.19%)
since 11/22/24
3-Month
80.64 +12.93%
on 10/30/24
91.93 -0.94%
on 11/22/24
+7.56 (+9.05%)
since 09/24/24
52-Week
55.69 +63.54%
on 12/26/23
91.93 -0.94%
on 11/22/24
+35.17 (+62.92%)
since 12/22/23

Most Recent Stories

More News
Medtronic Stock Declines 5.6% in a Month: Time to Buy the Dip?

Medtronic MDT closed at $79.99 in the last trading session, reflecting a 0.05% drop from the previous day. Broadly speaking, 2024 has not been smooth for investors in the Medical Products industry. Rising...

ABT : 114.76 (+0.39%)
BSX : 91.07 (+1.35%)
MDT : 81.54 (+0.17%)
BSX Trades Near 52-Week High: Does the Stock Hold More Potential?

Boston Scientific Corporation BSX remains in the spotlight, with its stock currently trading close to its 52-week high. In the past six trading sessions, the stock has consistently traded above $90.00...

ABT : 114.76 (+0.39%)
BSX : 91.07 (+1.35%)
MDT : 81.54 (+0.17%)
Is ResMed Stock Outperforming the Nasdaq?

ResMed has outpaced the broader Nasdaq Composite index over the past year, and Wall Street analysts are moderately bullish about the stock’s prospects.

$NASX : 20,031.13 (+1.35%)
BSX : 91.07 (+1.35%)
RMD : 232.58 (+0.61%)
How Is Stryker's Stock Performance Compared to Other Medical Device Stocks?

Stryker has substantially outpaced other medical device stocks over the past year and analysts remain strongly bullish on the stock’s prospects.

SYK : 370.78 (+1.17%)
BSX : 91.07 (+1.35%)
IHI : 59.30 (+0.73%)
Insider Sale: EVP of $BSX (BSX) Sells 6,983 Shares

Wendy Carruthers, the EVP of $BSX ($BSX), sold 6,983 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 19.2% of their shares....

BSX : 91.07 (+1.35%)
Is Boston Scientific Stock Outperforming the Dow?

Boston Scientific has outperformed the Dow recently, and analysts are strongly optimistic about the stock’s prospects.

BSX : 91.07 (+1.35%)
$DOWI : 43,297.03 (+0.91%)
MDT : 81.54 (+0.17%)
Insider Sale: EVP& Grp Pres of $BSX (BSX) Sells 14,010 Shares

Arthur C Butcher, the EVP& Grp Pres of $BSX ($BSX), sold 14,010 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 93.5% of their...

BSX : 91.07 (+1.35%)
Five Top Heart Health Stocks to Buy Heading into 2025

Heart health statistics are startling. Not only is heart disease the leading cause of death in the United States, it also claims the life of one person every 33 seconds. Plus, the estimated global annual...

ABT : 114.76 (+0.39%)
BSX : 91.07 (+1.35%)
CRDL : 1.2600 (+0.80%)
GILD : 93.95 (+0.59%)
MDT : 81.54 (+0.17%)
Top Analyst Reports for UnitedHealth, Bank of America & SAP

Wednesday, November 13, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth...

SONY : 21.14 (-0.09%)
SAP : 253.64 (+1.92%)
BAC : 44.38 (+1.12%)
BSX : 91.07 (+1.35%)
UNH : 506.10 (-0.05%)
SNY : 48.29 (-0.21%)
Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours

Alcon, Inc. ALC delivered core earnings per share (EPS) of 81 cents for the third quarter of 2024, up 22.7% from the year-ago quarter’s figure (up 25% at the constant exchange rate or CER). The figure...

DGX : 153.42 (+0.31%)
BSX : 91.07 (+1.35%)
RMD : 232.58 (+0.61%)
ALC : 86.08 (+0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and...

See More

Key Turning Points

3rd Resistance Point 92.98
2nd Resistance Point 92.04
1st Resistance Point 91.55
Last Price 91.07
1st Support Level 90.12
2nd Support Level 89.18
3rd Support Level 88.69

See More

52-Week High 91.93
Last Price 91.07
Fibonacci 61.8% 78.08
Fibonacci 50% 73.81
Fibonacci 38.2% 69.53
52-Week Low 55.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar